Concepedia

Kaiming Tao

KT

8

Publications

350

Citations

8

H-Index

2018

Active since

Affiliations

Stanford University(Current)

Temple University

University of California, Berkeley

Tufts Medical Center

University of California, San Francisco

Kaiming Tao is an author at Stanford University specializing in drug discovery, pharmacotherapy, and cell culture.

ORCID

Top concepts

Publications per year

2018–2024

8

Publications

8

Coronavirus Resistance Database (CoV-RDB): SARS-CoV-2 susceptibility to monoclonal antibodies, convalescent plasma, and plasma from vaccinated persons

Philip L. Tzou, Kaiming Tao, Sergei L. Kosakovsky Pond et al. · PLoS ONE · 2022 · 118 citations · Full text

Coronavirus Antiviral Research Database (CoV-RDB): An Online Database Designed to Facilitate Comparisons between Candidate Anti-Coronavirus Compounds

Philip L. Tzou, Kaiming Tao, Janin Nouhin et al. · Viruses · 2020 · 70 citations · Full text

Treatment Emergent Dolutegravir Resistance Mutations in Individuals Naïve to HIV-1 Integrase Inhibitors: A Rapid Scoping Review

Kaiming Tao, Soo‐Yon Rhee, Carolyn Chu et al. · Viruses · 2023 · 46 citations · Full text

Prevalence of Emergent Dolutegravir Resistance Mutations in People Living with HIV: A Rapid Scoping Review

Carolyn Chu, Kaiming Tao, Vinie Kouamou et al. · Viruses · 2024 · 46 citations · Full text

Facile synthesis of three-dimensional diatomite/manganese silicate nanosheet composites for enhanced Fenton-like catalytic degradation of malachite green dye

De Bin Jiang, Yunsong Yuan, Deqiang Zhao et al. · Journal of Nanoparticle Research · 2018 · 24 citations

, , +8

Rows per page

1–5 of 8